NO20005418L - Homogene farmasöytiske sammensetninger omfattende abacavir, lamivudin og zidovudin - Google Patents
Homogene farmasöytiske sammensetninger omfattende abacavir, lamivudin og zidovudinInfo
- Publication number
- NO20005418L NO20005418L NO20005418A NO20005418A NO20005418L NO 20005418 L NO20005418 L NO 20005418L NO 20005418 A NO20005418 A NO 20005418A NO 20005418 A NO20005418 A NO 20005418A NO 20005418 L NO20005418 L NO 20005418L
- Authority
- NO
- Norway
- Prior art keywords
- abacavir
- lamivudine
- zidovudine
- pharmaceutical compositions
- homogeneous pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9809213.3A GB9809213D0 (en) | 1998-04-29 | 1998-04-29 | Pharmaceutical compositions |
| PCT/EP1999/002794 WO1999055372A1 (en) | 1998-04-29 | 1999-04-26 | Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20005418D0 NO20005418D0 (no) | 2000-10-27 |
| NO20005418L true NO20005418L (no) | 2000-11-29 |
Family
ID=10831228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20005418A NO20005418L (no) | 1998-04-29 | 2000-10-27 | Homogene farmasöytiske sammensetninger omfattende abacavir, lamivudin og zidovudin |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1083932A1 (no) |
| JP (1) | JP2002512979A (no) |
| KR (1) | KR20010043128A (no) |
| CN (1) | CN1411380A (no) |
| AP (1) | AP2000001971A0 (no) |
| AU (1) | AU4135599A (no) |
| BR (1) | BR9910071A (no) |
| CA (1) | CA2330391A1 (no) |
| EA (1) | EA200000997A1 (no) |
| EE (1) | EE200000646A (no) |
| GB (1) | GB9809213D0 (no) |
| HR (1) | HRP20000732A2 (no) |
| HU (1) | HUP0101622A3 (no) |
| ID (1) | ID26955A (no) |
| IL (1) | IL139181A0 (no) |
| IS (1) | IS5675A (no) |
| NO (1) | NO20005418L (no) |
| NZ (1) | NZ507745A (no) |
| PL (1) | PL343710A1 (no) |
| SK (1) | SK16212000A3 (no) |
| TR (1) | TR200003157T2 (no) |
| WO (1) | WO1999055372A1 (no) |
| ZA (1) | ZA200005922B (no) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6875773B1 (en) | 1998-05-29 | 2005-04-05 | Ben M. Dunn | Combination therapy for treatment of FIV infection |
| EP1146882A2 (en) * | 1998-05-29 | 2001-10-24 | The University Of Florida | Combination of zidovudine (azt) with nucleoside analogs for treatment of feline immunodeficiency virus |
| GB9820417D0 (en) * | 1998-09-18 | 1998-11-11 | Glaxo Group Ltd | Antiviral combinations |
| US7074417B2 (en) * | 2000-10-13 | 2006-07-11 | Advancis Pharmaceutical Corporation | Multiple-delayed release anti-viral product, use and formulation thereof |
| EP1501521B1 (en) * | 2002-04-23 | 2007-05-02 | Lupin Limited | Long acting compositions comprising zidovudine and/or lamivudine |
| TW200403061A (en) * | 2002-06-04 | 2004-03-01 | Glaxo Group Ltd | Pharmaceutical compositions |
| CN100335125C (zh) * | 2003-06-03 | 2007-09-05 | 上海现代药物制剂工程研究中心 | 杀毒抗菌用长效干扰素喷鼻粉剂 |
| US20110104267A1 (en) * | 2005-04-25 | 2011-05-05 | Aurobindo Pharma Limited | Pharmaceutical compositions of antiretrovirals |
| US20070059360A1 (en) * | 2005-07-29 | 2007-03-15 | Ashish Jaiswal | Water-dispersible anti-retroviral pharmaceutical compositions |
| ES2279707B1 (es) * | 2005-11-10 | 2008-06-01 | Combino Pharm, S.L. | Formulaciones orales que comprenden 3'-azidonucleosidos. |
| BRPI0816498A2 (pt) * | 2007-10-02 | 2019-02-26 | Emory University | combinações potentes de zidovudina e drogas que selecionam para a mutuação k65r na polimerase do hiv |
| US20110117193A1 (en) * | 2008-01-17 | 2011-05-19 | Duquesne University Of The Holy Spirit | Antiretroviral drug formulations for treatment of children exposed to hiv/aids |
| RS54123B1 (sr) | 2010-01-27 | 2015-12-31 | Viiv Healthcare Company | Terapeutska kombinacija koja sadrži dolutegravir, abacavir i lamivudine |
| CN114010776A (zh) | 2010-06-09 | 2022-02-08 | 疫苗技术股份有限公司 | 用于增强抗逆转录病毒治疗的hiv感染者的治疗性免疫 |
| RU2014140177A (ru) | 2012-03-05 | 2016-04-27 | Сипла Лимитед | Фармацевтические антиретровирусные композиции |
| MX364901B (es) | 2012-10-23 | 2019-05-10 | Cipla Ltd | Composicion farmaceutica antirretroviral. |
| CN114404414A (zh) | 2013-06-13 | 2022-04-29 | 阿克比治疗有限公司 | 用于治疗贫血症的组合物和方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY115461A (en) * | 1995-03-30 | 2003-06-30 | Wellcome Found | Synergistic combinations of zidovudine, 1592u89 and 3tc |
| GB9622681D0 (en) * | 1996-10-31 | 1997-01-08 | Glaxo Group Ltd | Pharmaceutical compositions |
-
1998
- 1998-04-29 GB GBGB9809213.3A patent/GB9809213D0/en not_active Ceased
-
1999
- 1999-04-26 EE EEP200000646A patent/EE200000646A/xx unknown
- 1999-04-26 JP JP2000545569A patent/JP2002512979A/ja active Pending
- 1999-04-26 EA EA200000997A patent/EA200000997A1/ru unknown
- 1999-04-26 EP EP99924822A patent/EP1083932A1/en not_active Withdrawn
- 1999-04-26 IL IL13918199A patent/IL139181A0/xx unknown
- 1999-04-26 WO PCT/EP1999/002794 patent/WO1999055372A1/en not_active Ceased
- 1999-04-26 AU AU41355/99A patent/AU4135599A/en not_active Abandoned
- 1999-04-26 SK SK1621-2000A patent/SK16212000A3/sk unknown
- 1999-04-26 CA CA002330391A patent/CA2330391A1/en not_active Abandoned
- 1999-04-26 KR KR1020007012021A patent/KR20010043128A/ko not_active Withdrawn
- 1999-04-26 CN CN99807983A patent/CN1411380A/zh active Pending
- 1999-04-26 HU HU0101622A patent/HUP0101622A3/hu unknown
- 1999-04-26 BR BR9910071-1A patent/BR9910071A/pt not_active IP Right Cessation
- 1999-04-26 HR HR20000732A patent/HRP20000732A2/hr not_active Application Discontinuation
- 1999-04-26 PL PL99343710A patent/PL343710A1/xx unknown
- 1999-04-26 NZ NZ507745A patent/NZ507745A/en unknown
- 1999-04-26 ID IDW20002479A patent/ID26955A/id unknown
- 1999-04-26 AP APAP/P/2000/001971A patent/AP2000001971A0/en unknown
- 1999-04-26 TR TR2000/03157T patent/TR200003157T2/xx unknown
-
2000
- 2000-10-20 IS IS5675A patent/IS5675A/is unknown
- 2000-10-23 ZA ZA200005922A patent/ZA200005922B/xx unknown
- 2000-10-27 NO NO20005418A patent/NO20005418L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EE200000646A (et) | 2002-04-15 |
| AU4135599A (en) | 1999-11-16 |
| HRP20000732A2 (en) | 2001-02-28 |
| IL139181A0 (en) | 2001-11-25 |
| KR20010043128A (ko) | 2001-05-25 |
| ID26955A (id) | 2001-02-22 |
| AP2000001971A0 (en) | 2000-12-31 |
| NO20005418D0 (no) | 2000-10-27 |
| NZ507745A (en) | 2004-07-30 |
| CN1411380A (zh) | 2003-04-16 |
| CA2330391A1 (en) | 1999-11-04 |
| EA200000997A1 (ru) | 2001-06-25 |
| BR9910071A (pt) | 2000-12-26 |
| HUP0101622A3 (en) | 2003-09-29 |
| SK16212000A3 (sk) | 2001-07-10 |
| IS5675A (is) | 2000-10-20 |
| GB9809213D0 (en) | 1998-07-01 |
| PL343710A1 (en) | 2001-08-27 |
| EP1083932A1 (en) | 2001-03-21 |
| JP2002512979A (ja) | 2002-05-08 |
| WO1999055372A1 (en) | 1999-11-04 |
| ZA200005922B (en) | 2001-10-23 |
| HUP0101622A2 (hu) | 2002-03-28 |
| TR200003157T2 (tr) | 2001-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20005418L (no) | Homogene farmasöytiske sammensetninger omfattende abacavir, lamivudin og zidovudin | |
| DK1095016T3 (da) | Svovlsubstituerede sulfonylaminocarboxylsyre-N-arylamider, deres fremstilling, deres anvendelse og farmaceutiske præparater omfattende dem | |
| EA199900373A3 (ru) | Фармацевтические композиции | |
| NO20002359L (no) | Adenosinderivater og farmasoytisk sammensetning inneholdende derivatene | |
| NO20001409D0 (no) | Karboksamidotiazolderivater, fremgangsmåte for fremstilling derav og farmasøytiske blandinger | |
| NO20024355D0 (no) | Nukleosidforbindelser og anvendelser derav | |
| NO20005913D0 (no) | Legemiddelsammensetning | |
| ID26549A (id) | Komposisi-komposisi epotilon | |
| ATE367793T1 (de) | Schweisshemmende zusammensetzungen | |
| DK1112266T3 (da) | Substituerede 4-amino-2-arylpyrimidiner, fremstilling og anvendelse deraf og farmaceutiske præparater indeholdende dem | |
| DE69904699D1 (de) | Pestizide Zusammensetzungen | |
| NO20006520L (no) | Adenosinderivater | |
| ATE469550T1 (de) | Antiparasitäre zusammensetzungen | |
| DE69927758D1 (de) | Imidosilan-Zusammensetzungen | |
| DE69807911D1 (de) | Vernetzbare zusammensetzung | |
| NO20004160L (no) | Langrenns- eller turskibinding | |
| ID27201A (id) | Komposisi farmasi | |
| IS6677A (is) | Amínóalkýlbensóýl-bensófúran eða bensóþíófenafleiður, aðferð til framleiðslu þeirra og samsetningarsem innihalda þær | |
| IS5827A (is) | Múskarín gerandefni og mótlyf | |
| FR2787721B1 (fr) | Compositions extinctrices | |
| ID22405A (id) | Komposisi pestisida | |
| DE69820498D1 (de) | Fungizide Mischung, enthaltend ein N-Acetonylbenzamid und Fluazinam | |
| IS5024A (is) | Lyfjasamsetningar sem innihalda lamivúdín og zídóvúdín | |
| ID26215A (id) | Komposisi farmasi | |
| DE59903011D1 (de) | Kalibrierverfahren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |